Preface with Jan Peter Balkenende & Rutger Baan Noaber Foundation
Jan Peter Balkenende
2020 was an eventful year. An incredible number of events and changes have taken place since we were confronted with the COVID-19 pandemic. We suddenly had to ask each other all kinds of questions and come up with solutions. Working online, for instance, is becoming the norm. And how would the organizations and companies in our programs and portfolios do? What were they facing and what risks would both parties be exposed to?
2020 was also the year in which the transition from the first generation (our founders) to the second generation (their children) was prepared. This was quite a complex process. For example, we had to deal with the transition from an enterprising founder company, to a more enterprising organization. The main lesson we learned from our parents in this regard is that planning, risk assessments, etc. are useful. However, at the same time, you also have to have a “go for it” mentality when you believe you can achieve something great.Full preface
Preface with Matthijs Blokhuis - CEO Noaber
Driving change and improving health, define both the role we want to play, and the goal Noaber wants to achieve. This ambition is more relevant than ever! We put everything we have towards enhancing the health span of society and of every person that is part of that society. We strive to make the world healthier and more sustainable through innovation and deliver on quadruple aim.
Not only through the activities, programs and participations supported by Noaber, but also by taking an initiating and accelerating role to enable a system based collaborative approach that integrates stakeholder interests and perspectives that provides the foundation for a sustainable transition.
Seriously ill patients are treated in the Nursing Department of Pulmonary Medicine of the Franciscus Gasthuis [Hospital] in Rotterdam. All patients are continuously remotely monitored via contactless technology, called the EarlySense system.
Transparency is the currency of trust.
Freda Lewis-Hall, MD
Chief Medical Officer Pfizer Inc.